60 participants
A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-27
- Start Date:
- 2024-12-15
- Completion:
- 2026-10-31
Conditions
- Hidradenitis Suppurativa
Interventions
- DRUG
No Results Yet